nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—Buffalo hump—Prednisone—ankylosing spondylitis	0.0268	0.0288	CcSEcCtD
Didanosine—Sickness—Prednisolone—ankylosing spondylitis	0.0267	0.0286	CcSEcCtD
Didanosine—Lipohypertrophy—Prednisone—ankylosing spondylitis	0.0246	0.0264	CcSEcCtD
Didanosine—Leukoderma—Prednisolone—ankylosing spondylitis	0.0174	0.0187	CcSEcCtD
Didanosine—Leukoderma—Triamcinolone—ankylosing spondylitis	0.016	0.0172	CcSEcCtD
Didanosine—Leukoderma—Methylprednisolone—ankylosing spondylitis	0.016	0.0172	CcSEcCtD
Didanosine—PNP—Balsalazide—Sulfasalazine—ankylosing spondylitis	0.0159	0.232	CbGdCrCtD
Didanosine—Leukoderma—Betamethasone—ankylosing spondylitis	0.0145	0.0156	CcSEcCtD
Didanosine—Leukoderma—Dexamethasone—ankylosing spondylitis	0.0145	0.0156	CcSEcCtD
Didanosine—Leukoderma—Prednisone—ankylosing spondylitis	0.0127	0.0136	CcSEcCtD
Didanosine—Retinal disorder—Methotrexate—ankylosing spondylitis	0.0126	0.0135	CcSEcCtD
Didanosine—Optic neuritis—Prednisolone—ankylosing spondylitis	0.012	0.0129	CcSEcCtD
Didanosine—Optic neuritis—Triamcinolone—ankylosing spondylitis	0.0111	0.0119	CcSEcCtD
Didanosine—Optic neuritis—Methylprednisolone—ankylosing spondylitis	0.011	0.0119	CcSEcCtD
Didanosine—Leukoderma—Methotrexate—ankylosing spondylitis	0.0106	0.0114	CcSEcCtD
Didanosine—Myopathy—Prednisolone—ankylosing spondylitis	0.0106	0.0113	CcSEcCtD
Didanosine—Hepatomegaly—Prednisolone—ankylosing spondylitis	0.0105	0.0112	CcSEcCtD
Didanosine—Optic neuritis—Dexamethasone—ankylosing spondylitis	0.01	0.0108	CcSEcCtD
Didanosine—Optic neuritis—Betamethasone—ankylosing spondylitis	0.01	0.0108	CcSEcCtD
Didanosine—Neuritis—Prednisolone—ankylosing spondylitis	0.00992	0.0106	CcSEcCtD
Didanosine—Myopathy—Triamcinolone—ankylosing spondylitis	0.00971	0.0104	CcSEcCtD
Didanosine—Myopathy—Methylprednisolone—ankylosing spondylitis	0.00969	0.0104	CcSEcCtD
Didanosine—Hepatomegaly—Triamcinolone—ankylosing spondylitis	0.00962	0.0103	CcSEcCtD
Didanosine—Hepatomegaly—Methylprednisolone—ankylosing spondylitis	0.0096	0.0103	CcSEcCtD
Didanosine—Nephropathy—Methotrexate—ankylosing spondylitis	0.00944	0.0101	CcSEcCtD
Didanosine—Neuritis—Triamcinolone—ankylosing spondylitis	0.00912	0.00979	CcSEcCtD
Didanosine—Neuritis—Methylprednisolone—ankylosing spondylitis	0.0091	0.00977	CcSEcCtD
Didanosine—Myopathy—Betamethasone—ankylosing spondylitis	0.00881	0.00945	CcSEcCtD
Didanosine—Myopathy—Dexamethasone—ankylosing spondylitis	0.00881	0.00945	CcSEcCtD
Didanosine—Optic neuritis—Prednisone—ankylosing spondylitis	0.00875	0.00939	CcSEcCtD
Didanosine—Hepatomegaly—Dexamethasone—ankylosing spondylitis	0.00873	0.00937	CcSEcCtD
Didanosine—Hepatomegaly—Betamethasone—ankylosing spondylitis	0.00873	0.00937	CcSEcCtD
Didanosine—Tingling sensation—Methylprednisolone—ankylosing spondylitis	0.00845	0.00907	CcSEcCtD
Didanosine—Neuritis—Dexamethasone—ankylosing spondylitis	0.00827	0.00888	CcSEcCtD
Didanosine—Neuritis—Betamethasone—ankylosing spondylitis	0.00827	0.00888	CcSEcCtD
Didanosine—Tingling sensation—Dexamethasone—ankylosing spondylitis	0.00768	0.00825	CcSEcCtD
Didanosine—Tingling sensation—Betamethasone—ankylosing spondylitis	0.00768	0.00825	CcSEcCtD
Didanosine—Myopathy—Prednisone—ankylosing spondylitis	0.00767	0.00823	CcSEcCtD
Didanosine—Hepatomegaly—Prednisone—ankylosing spondylitis	0.0076	0.00816	CcSEcCtD
Didanosine—Neuritis—Prednisone—ankylosing spondylitis	0.00721	0.00773	CcSEcCtD
Didanosine—Inflammation—Methylprednisolone—ankylosing spondylitis	0.007	0.00752	CcSEcCtD
Didanosine—Neuropathy—Prednisolone—ankylosing spondylitis	0.00695	0.00746	CcSEcCtD
Didanosine—Neuropathy—Triamcinolone—ankylosing spondylitis	0.00639	0.00686	CcSEcCtD
Didanosine—Neuropathy—Methylprednisolone—ankylosing spondylitis	0.00638	0.00685	CcSEcCtD
Didanosine—Diabetes mellitus—Prednisolone—ankylosing spondylitis	0.00618	0.00663	CcSEcCtD
Didanosine—Hepatotoxicity—Methotrexate—ankylosing spondylitis	0.00582	0.00625	CcSEcCtD
Didanosine—Neuropathy—Dexamethasone—ankylosing spondylitis	0.0058	0.00623	CcSEcCtD
Didanosine—Neuropathy—Betamethasone—ankylosing spondylitis	0.0058	0.00623	CcSEcCtD
Didanosine—Dry eye—Betamethasone—ankylosing spondylitis	0.00571	0.00612	CcSEcCtD
Didanosine—Dry eye—Dexamethasone—ankylosing spondylitis	0.00571	0.00612	CcSEcCtD
Didanosine—Diabetes mellitus—Triamcinolone—ankylosing spondylitis	0.00568	0.0061	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.00567	0.00608	CcSEcCtD
Didanosine—Diabetes mellitus—Methylprednisolone—ankylosing spondylitis	0.00567	0.00608	CcSEcCtD
Didanosine—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.00555	0.00596	CcSEcCtD
Didanosine—Diabetes mellitus—Betamethasone—ankylosing spondylitis	0.00516	0.00553	CcSEcCtD
Didanosine—Diabetes mellitus—Dexamethasone—ankylosing spondylitis	0.00516	0.00553	CcSEcCtD
Didanosine—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.00511	0.00548	CcSEcCtD
Didanosine—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.00509	0.00547	CcSEcCtD
Didanosine—Neuropathy—Prednisone—ankylosing spondylitis	0.00505	0.00542	CcSEcCtD
Didanosine—Hyperuricaemia—Methotrexate—ankylosing spondylitis	0.00485	0.0052	CcSEcCtD
Didanosine—Inflammation—Methotrexate—ankylosing spondylitis	0.00464	0.00498	CcSEcCtD
Didanosine—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.00463	0.00497	CcSEcCtD
Didanosine—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.00463	0.00497	CcSEcCtD
Didanosine—Blood uric acid increased—Methotrexate—ankylosing spondylitis	0.00458	0.00491	CcSEcCtD
Didanosine—Pancreatitis—Prednisolone—ankylosing spondylitis	0.00455	0.00489	CcSEcCtD
Didanosine—Diabetes mellitus—Prednisone—ankylosing spondylitis	0.00449	0.00482	CcSEcCtD
Didanosine—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.00419	0.00449	CcSEcCtD
Didanosine—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.00418	0.00448	CcSEcCtD
Didanosine—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.00406	0.00436	CcSEcCtD
Didanosine—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.00375	0.00403	CcSEcCtD
Didanosine—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.00373	0.00401	CcSEcCtD
Didanosine—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.00372	0.004	CcSEcCtD
Didanosine—Hepatic failure—Methotrexate—ankylosing spondylitis	0.00363	0.0039	CcSEcCtD
Didanosine—Renal failure acute—Methotrexate—ankylosing spondylitis	0.00353	0.00379	CcSEcCtD
Didanosine—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.0035	0.00375	CcSEcCtD
Didanosine—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.0035	0.00375	CcSEcCtD
Didanosine—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.00339	0.00364	CcSEcCtD
Didanosine—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.00339	0.00364	CcSEcCtD
Didanosine—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.00337	0.00362	CcSEcCtD
Didanosine—Pancreatitis—Prednisone—ankylosing spondylitis	0.00331	0.00355	CcSEcCtD
Didanosine—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00304	0.00327	CcSEcCtD
Didanosine—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00295	0.00317	CcSEcCtD
Didanosine—Malaise—Prednisolone—ankylosing spondylitis	0.00292	0.00313	CcSEcCtD
Didanosine—Pancreatitis—Methotrexate—ankylosing spondylitis	0.00277	0.00297	CcSEcCtD
Didanosine—Alopecia—Dexamethasone—ankylosing spondylitis	0.00274	0.00294	CcSEcCtD
Didanosine—Alopecia—Betamethasone—ankylosing spondylitis	0.00274	0.00294	CcSEcCtD
Didanosine—Discomfort—Prednisolone—ankylosing spondylitis	0.00272	0.00292	CcSEcCtD
Didanosine—Malaise—Triamcinolone—ankylosing spondylitis	0.00268	0.00288	CcSEcCtD
Didanosine—Malaise—Methylprednisolone—ankylosing spondylitis	0.00268	0.00287	CcSEcCtD
Didanosine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00264	0.00284	CcSEcCtD
Didanosine—PNP—Clobetasol propionate—Methylprednisolone—ankylosing spondylitis	0.0026	0.0381	CbGdCrCtD
Didanosine—PNP—Flunisolide—Methylprednisolone—ankylosing spondylitis	0.00257	0.0376	CbGdCrCtD
Didanosine—PNP—Clobetasol propionate—Betamethasone—ankylosing spondylitis	0.00256	0.0375	CbGdCrCtD
Didanosine—PNP—Clobetasol propionate—Dexamethasone—ankylosing spondylitis	0.00256	0.0375	CbGdCrCtD
Didanosine—Myalgia—Triamcinolone—ankylosing spondylitis	0.00253	0.00272	CcSEcCtD
Didanosine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00253	0.00271	CcSEcCtD
Didanosine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00253	0.00271	CcSEcCtD
Didanosine—PNP—Flunisolide—Betamethasone—ankylosing spondylitis	0.00253	0.037	CbGdCrCtD
Didanosine—PNP—Flunisolide—Dexamethasone—ankylosing spondylitis	0.00253	0.037	CbGdCrCtD
Didanosine—Discomfort—Triamcinolone—ankylosing spondylitis	0.0025	0.00269	CcSEcCtD
Didanosine—PNP—Clobetasol propionate—Triamcinolone—ankylosing spondylitis	0.0025	0.0366	CbGdCrCtD
Didanosine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.0025	0.00268	CcSEcCtD
Didanosine—PNP—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.00248	0.0363	CbGdCrCtD
Didanosine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00248	0.00266	CcSEcCtD
Didanosine—PNP—Flunisolide—Triamcinolone—ankylosing spondylitis	0.00247	0.0362	CbGdCrCtD
Didanosine—PNP—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.00244	0.0357	CbGdCrCtD
Didanosine—PNP—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.00244	0.0357	CbGdCrCtD
Didanosine—Malaise—Betamethasone—ankylosing spondylitis	0.00244	0.00261	CcSEcCtD
Didanosine—Malaise—Dexamethasone—ankylosing spondylitis	0.00244	0.00261	CcSEcCtD
Didanosine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00243	0.00261	CcSEcCtD
Didanosine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00242	0.0026	CcSEcCtD
Didanosine—Infection—Triamcinolone—ankylosing spondylitis	0.00241	0.00259	CcSEcCtD
Didanosine—Infection—Methylprednisolone—ankylosing spondylitis	0.00241	0.00258	CcSEcCtD
Didanosine—Alopecia—Prednisone—ankylosing spondylitis	0.00239	0.00256	CcSEcCtD
Didanosine—PNP—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.00238	0.0349	CbGdCrCtD
Didanosine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00238	0.00255	CcSEcCtD
Didanosine—PNP—Clobetasol propionate—Prednisone—ankylosing spondylitis	0.00238	0.0348	CbGdCrCtD
Didanosine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00237	0.00255	CcSEcCtD
Didanosine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00235	0.00252	CcSEcCtD
Didanosine—PNP—Flunisolide—Prednisone—ankylosing spondylitis	0.00234	0.0343	CbGdCrCtD
Didanosine—PNP—Fluocinolone Acetonide—Methylprednisolone—ankylosing spondylitis	0.00234	0.0342	CbGdCrCtD
Didanosine—PNP—Clobetasol propionate—Prednisolone—ankylosing spondylitis	0.00232	0.0339	CbGdCrCtD
Didanosine—PNP—Fluocinolone Acetonide—Betamethasone—ankylosing spondylitis	0.0023	0.0337	CbGdCrCtD
Didanosine—PNP—Fluocinolone Acetonide—Dexamethasone—ankylosing spondylitis	0.0023	0.0337	CbGdCrCtD
Didanosine—Myalgia—Dexamethasone—ankylosing spondylitis	0.0023	0.00247	CcSEcCtD
Didanosine—Myalgia—Betamethasone—ankylosing spondylitis	0.0023	0.00247	CcSEcCtD
Didanosine—PNP—Flunisolide—Prednisolone—ankylosing spondylitis	0.00229	0.0335	CbGdCrCtD
Didanosine—Discomfort—Dexamethasone—ankylosing spondylitis	0.00227	0.00244	CcSEcCtD
Didanosine—Discomfort—Betamethasone—ankylosing spondylitis	0.00227	0.00244	CcSEcCtD
Didanosine—Pain—Prednisolone—ankylosing spondylitis	0.00226	0.00242	CcSEcCtD
Didanosine—Hepatitis—Methotrexate—ankylosing spondylitis	0.00226	0.00242	CcSEcCtD
Didanosine—PNP—Fluocinolone Acetonide—Triamcinolone—ankylosing spondylitis	0.00225	0.0329	CbGdCrCtD
Didanosine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00221	0.00238	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00221	0.00237	CcSEcCtD
Didanosine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.0022	0.00237	CcSEcCtD
Didanosine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.0022	0.00237	CcSEcCtD
Didanosine—Infection—Betamethasone—ankylosing spondylitis	0.00219	0.00235	CcSEcCtD
Didanosine—Infection—Dexamethasone—ankylosing spondylitis	0.00219	0.00235	CcSEcCtD
Didanosine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00218	0.00234	CcSEcCtD
Didanosine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00218	0.00234	CcSEcCtD
Didanosine—Anaemia—Prednisone—ankylosing spondylitis	0.00217	0.00233	CcSEcCtD
Didanosine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00216	0.00232	CcSEcCtD
Didanosine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00216	0.00232	CcSEcCtD
Didanosine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00214	0.00229	CcSEcCtD
Didanosine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00213	0.00229	CcSEcCtD
Didanosine—Malaise—Prednisone—ankylosing spondylitis	0.00212	0.00228	CcSEcCtD
Didanosine—Anorexia—Dexamethasone—ankylosing spondylitis	0.0021	0.00225	CcSEcCtD
Didanosine—Anorexia—Betamethasone—ankylosing spondylitis	0.0021	0.00225	CcSEcCtD
Didanosine—PNP—Fluocinolone Acetonide—Prednisolone—ankylosing spondylitis	0.00208	0.0305	CbGdCrCtD
Didanosine—Pain—Triamcinolone—ankylosing spondylitis	0.00208	0.00223	CcSEcCtD
Didanosine—Chills—Methotrexate—ankylosing spondylitis	0.00203	0.00217	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00201	0.00216	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00201	0.00216	CcSEcCtD
Didanosine—Arthralgia—Prednisone—ankylosing spondylitis	0.002	0.00215	CcSEcCtD
Didanosine—Myalgia—Prednisone—ankylosing spondylitis	0.002	0.00215	CcSEcCtD
Didanosine—Alopecia—Methotrexate—ankylosing spondylitis	0.002	0.00214	CcSEcCtD
Didanosine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00198	0.00213	CcSEcCtD
Didanosine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00198	0.00212	CcSEcCtD
Didanosine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00198	0.00212	CcSEcCtD
Didanosine—Discomfort—Prednisone—ankylosing spondylitis	0.00198	0.00212	CcSEcCtD
Didanosine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00195	0.00209	CcSEcCtD
Didanosine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00194	0.00208	CcSEcCtD
Didanosine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00194	0.00208	CcSEcCtD
Didanosine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00192	0.00206	CcSEcCtD
Didanosine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00192	0.00206	CcSEcCtD
Didanosine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00192	0.00206	CcSEcCtD
Didanosine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00192	0.00206	CcSEcCtD
Didanosine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00192	0.00206	CcSEcCtD
Didanosine—Infection—Prednisone—ankylosing spondylitis	0.00191	0.00205	CcSEcCtD
Didanosine—Pain—Dexamethasone—ankylosing spondylitis	0.00188	0.00202	CcSEcCtD
Didanosine—Pain—Betamethasone—ankylosing spondylitis	0.00188	0.00202	CcSEcCtD
Didanosine—Anorexia—Prednisone—ankylosing spondylitis	0.00183	0.00196	CcSEcCtD
Didanosine—Anaemia—Methotrexate—ankylosing spondylitis	0.00182	0.00195	CcSEcCtD
Didanosine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.0018	0.00193	CcSEcCtD
Didanosine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.0018	0.00193	CcSEcCtD
Didanosine—PNP—Danazol—Prednisone—ankylosing spondylitis	0.0018	0.0263	CbGdCrCtD
Didanosine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00179	0.00192	CcSEcCtD
Didanosine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00179	0.00192	CcSEcCtD
Didanosine—Malaise—Methotrexate—ankylosing spondylitis	0.00177	0.0019	CcSEcCtD
Didanosine—Leukopenia—Methotrexate—ankylosing spondylitis	0.00176	0.00189	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00175	0.00188	CcSEcCtD
Didanosine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00174	0.00187	CcSEcCtD
Didanosine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00174	0.00187	CcSEcCtD
Didanosine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00174	0.00187	CcSEcCtD
Didanosine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00174	0.00187	CcSEcCtD
Didanosine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00174	0.00187	CcSEcCtD
Didanosine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00174	0.00187	CcSEcCtD
Didanosine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00172	0.00185	CcSEcCtD
Didanosine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00172	0.00184	CcSEcCtD
Didanosine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00171	0.00184	CcSEcCtD
Didanosine—Dyspepsia—Prednisone—ankylosing spondylitis	0.00169	0.00181	CcSEcCtD
Didanosine—Myalgia—Methotrexate—ankylosing spondylitis	0.00167	0.0018	CcSEcCtD
Didanosine—Arthralgia—Methotrexate—ankylosing spondylitis	0.00167	0.0018	CcSEcCtD
Didanosine—Decreased appetite—Prednisone—ankylosing spondylitis	0.00167	0.00179	CcSEcCtD
Didanosine—Rash—Prednisolone—ankylosing spondylitis	0.00167	0.00179	CcSEcCtD
Didanosine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00166	0.00179	CcSEcCtD
Didanosine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00166	0.00178	CcSEcCtD
Didanosine—Headache—Prednisolone—ankylosing spondylitis	0.00165	0.00178	CcSEcCtD
Didanosine—Discomfort—Methotrexate—ankylosing spondylitis	0.00165	0.00177	CcSEcCtD
Didanosine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.0016	0.00172	CcSEcCtD
Didanosine—Infection—Methotrexate—ankylosing spondylitis	0.00159	0.00171	CcSEcCtD
Didanosine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00158	0.0017	CcSEcCtD
Didanosine—Asthenia—Betamethasone—ankylosing spondylitis	0.00158	0.0017	CcSEcCtD
Didanosine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00157	0.00169	CcSEcCtD
Didanosine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00157	0.00168	CcSEcCtD
Didanosine—Nausea—Prednisolone—ankylosing spondylitis	0.00157	0.00168	CcSEcCtD
Didanosine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00156	0.00167	CcSEcCtD
Didanosine—Pruritus—Betamethasone—ankylosing spondylitis	0.00156	0.00167	CcSEcCtD
Didanosine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00154	0.00166	CcSEcCtD
Didanosine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00154	0.00165	CcSEcCtD
Didanosine—Rash—Triamcinolone—ankylosing spondylitis	0.00153	0.00164	CcSEcCtD
Didanosine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00153	0.00164	CcSEcCtD
Didanosine—Anorexia—Methotrexate—ankylosing spondylitis	0.00153	0.00164	CcSEcCtD
Didanosine—Rash—Methylprednisolone—ankylosing spondylitis	0.00153	0.00164	CcSEcCtD
Didanosine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00153	0.00164	CcSEcCtD
Didanosine—Headache—Triamcinolone—ankylosing spondylitis	0.00152	0.00163	CcSEcCtD
Didanosine—Headache—Methylprednisolone—ankylosing spondylitis	0.00152	0.00163	CcSEcCtD
Didanosine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00152	0.00163	CcSEcCtD
Didanosine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00152	0.00163	CcSEcCtD
Didanosine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00151	0.00162	CcSEcCtD
Didanosine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00151	0.00162	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00146	0.00157	CcSEcCtD
Didanosine—Nausea—Triamcinolone—ankylosing spondylitis	0.00144	0.00155	CcSEcCtD
Didanosine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00144	0.00155	CcSEcCtD
Didanosine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00144	0.00155	CcSEcCtD
Didanosine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00141	0.00152	CcSEcCtD
Didanosine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00141	0.00152	CcSEcCtD
Didanosine—Vomiting—Betamethasone—ankylosing spondylitis	0.0014	0.0015	CcSEcCtD
Didanosine—Vomiting—Dexamethasone—ankylosing spondylitis	0.0014	0.0015	CcSEcCtD
Didanosine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00139	0.0015	CcSEcCtD
Didanosine—Rash—Betamethasone—ankylosing spondylitis	0.00139	0.00149	CcSEcCtD
Didanosine—Rash—Dexamethasone—ankylosing spondylitis	0.00139	0.00149	CcSEcCtD
Didanosine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00139	0.00149	CcSEcCtD
Didanosine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00139	0.00149	CcSEcCtD
Didanosine—Headache—Dexamethasone—ankylosing spondylitis	0.00138	0.00148	CcSEcCtD
Didanosine—Headache—Betamethasone—ankylosing spondylitis	0.00138	0.00148	CcSEcCtD
Didanosine—Asthenia—Prednisone—ankylosing spondylitis	0.00138	0.00148	CcSEcCtD
Didanosine—Pain—Methotrexate—ankylosing spondylitis	0.00137	0.00147	CcSEcCtD
Didanosine—Pruritus—Prednisone—ankylosing spondylitis	0.00136	0.00146	CcSEcCtD
Didanosine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00131	0.00141	CcSEcCtD
Didanosine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00131	0.00141	CcSEcCtD
Didanosine—Nausea—Dexamethasone—ankylosing spondylitis	0.00131	0.00141	CcSEcCtD
Didanosine—Nausea—Betamethasone—ankylosing spondylitis	0.00131	0.00141	CcSEcCtD
Didanosine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00127	0.00136	CcSEcCtD
Didanosine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00127	0.00136	CcSEcCtD
Didanosine—Vomiting—Prednisone—ankylosing spondylitis	0.00122	0.00131	CcSEcCtD
Didanosine—Rash—Prednisone—ankylosing spondylitis	0.00121	0.0013	CcSEcCtD
Didanosine—Dermatitis—Prednisone—ankylosing spondylitis	0.00121	0.0013	CcSEcCtD
Didanosine—Headache—Prednisone—ankylosing spondylitis	0.0012	0.00129	CcSEcCtD
Didanosine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00118	0.00127	CcSEcCtD
Didanosine—Asthenia—Methotrexate—ankylosing spondylitis	0.00115	0.00124	CcSEcCtD
Didanosine—Nausea—Prednisone—ankylosing spondylitis	0.00114	0.00122	CcSEcCtD
Didanosine—Pruritus—Methotrexate—ankylosing spondylitis	0.00113	0.00122	CcSEcCtD
Didanosine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.0011	0.00118	CcSEcCtD
Didanosine—Vomiting—Methotrexate—ankylosing spondylitis	0.00102	0.00109	CcSEcCtD
Didanosine—Rash—Methotrexate—ankylosing spondylitis	0.00101	0.00109	CcSEcCtD
Didanosine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00101	0.00108	CcSEcCtD
Didanosine—Headache—Methotrexate—ankylosing spondylitis	0.001	0.00108	CcSEcCtD
Didanosine—Nausea—Methotrexate—ankylosing spondylitis	0.000953	0.00102	CcSEcCtD
